<< Back to Results
ECOG E5202 - A Randomized Phase III Study Comparing 5 F-U, Leucovorin and Oxaliplatin versus 5 FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers.
Clinical Trial Categories
- The Rosenfeld Cancer Center at 215-481-2402
- The Rosenfeld Cancer Center